[Is immediate coronary angioplasty the best treatment in acute myocardial infarction?]. 1996

J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
Department of Internal Medicine, Oulu Central University Hospital, Finland.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015906 Angioplasty, Balloon, Coronary Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply. Angioplasty, Coronary Balloon,Angioplasty, Transluminal, Percutaneous Coronary,Coronary Angioplasty, Transluminal Balloon,Percutaneous Transluminal Coronary Angioplasty,Balloon Dilation, Coronary Artery,Transluminal Coronary Balloon Dilation,Angioplasties, Coronary Balloon,Balloon Angioplasties, Coronary,Balloon Angioplasty, Coronary,Coronary Balloon Angioplasties,Coronary Balloon Angioplasty
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
December 1995, Presse medicale (Paris, France : 1983),
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
June 1993, BMJ (Clinical research ed.),
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
January 1994, Revista espanola de cardiologia,
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
March 1993, The New England journal of medicine,
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
November 1985, Missouri medicine,
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
January 1987, Catheterization and cardiovascular diagnosis,
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
July 1997, Cardiologia (Rome, Italy),
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
October 1996, Obstetrics and gynecology,
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
January 1988, Catheterization and cardiovascular diagnosis,
J Airaksinen, and E Poikela, and M Niemelä, and A Ylitalo, and M Ikäheimo
May 1995, Giornale italiano di cardiologia,
Copied contents to your clipboard!